[1] |
Rageade F, Picot N, Blanc-Michaud A , et al. Performance of solid and liquid culture media for the detection of Mycobacterium tuberculosis in clinical materials: meta-analysis of recent studies. Eur J Clin Microbiol Infect Dis, 2014,33(6):867-870.
doi: 10.1007/s10096-014-2105-z
URL
pmid: 24760249
|
[2] |
赵雁林, 逄宇 . 结核病实验室检验规程.北京: 人民卫生出版社, 2015.
|
[3] |
Abbadi SH, Sameaa GA, Morlock G , et al. Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Int J Infect Dis, 2009,13(6):673-678.
doi: 10.1016/j.ijid.2008.10.006
URL
pmid: 19138546
|
[4] |
王福保, 闵华玲, 叶润修 . 概率论及数理统计. 上海: 上海同济大学出版杜, 1984.
|
[5] |
Singhal R, Myneedu VP, Arora J , et al. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North-Eastern States of India using GenoType MTBDRplus assay. Indian J Med Res, 2014,140(4):501-506.
|
[6] |
Sharma SK, Kohli M, Yadav RN , et al. Evaluating the diagnostic accuracy of Xpert MTB/RIF assay in pulmonary tuberculosis. PLoS One, 2015,10(10):e0141011.
doi: 10.1371/journal.pone.0141011
URL
pmid: 4619889
|
[7] |
Rahman A, Sahrin M, Afrin S , et al. Comparison of Xpert MTB/RIF assay and GenoType MTBDRplus DNA probes for detection of mutations associated with rifampicin resistance in Mycobacterium tuberculosis. PLoS One, 2016,11(4):e0152694.
doi: 10.1371/journal.pone.0152694
URL
pmid: 27054344
|
[8] |
Seifert M, Ajbani K, Georghiou SB , et al. A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis, 2016,20(5):631-637.
doi: 10.5588/ijtld.15.0788
URL
pmid: 27084817
|
[9] |
Huang H, Jin Q, Ma Y , et al. Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China. Tuberculosis (Edinb), 2002,82(2/3):79-83.
|
[10] |
Tessema B, Beer J, Emmrich F , et al. Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia. BMC Infect Dis, 2012,12:37.
doi: 10.1186/1471-2334-12-37
URL
pmid: 3378438
|
[11] |
Causse M, Ruiz P, Gutierrez JB , et al. New Anyplex ® Ⅱ MTB/MDR/XDR kit for detection of resistance mutations in M.tuberculosis cultures . Int J Tuberc Lung Dis, 2015,19(12):1542-1546.
|
[12] |
Jin J, Zhang Y, Fan X , et al. Evaluation of the GenoType ® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection . Int J Tuberc Lung Dis, 2012,16(4):521-526.
doi: 10.5588/ijtld.11.0269
URL
pmid: 22325117
|
[13] |
Yadav RN, Singh BK, Sharma SK , et al. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India. PLoS One, 2013,8(9):e72036.
doi: 10.1371/journal.pone.0072036
URL
pmid: 3764192
|
[14] |
林百丰, 王鑫, 唐鹭 , 等. GeneXpert MTB/RIF检测肺结核患者痰标本的应用价值. 结核病与肺部健康杂志, 2018,7(3):185-187.
|
[15] |
Hu S, Li G, Li H , et al. Rapid detection of isoniazid resis-tance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis. J Clin Microbiol, 2014,52(5):1644-1652.
doi: 10.1128/JCM.03395-13
|
[16] |
杨新宇, 李波, 赵琰枫 , 等. 564例肺结核患者痰标本质量对检测结果的影响. 结核病与肺部健康杂志, 2018,7(2):109-113.
|
[17] |
Huitric E, Werngren J, Juréen P , et al. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob Agents Chemother, 2006,50(8):2860-2862.
doi: 10.1109/MIA.2004.1270806
URL
|
[18] |
刘宇红, 王甦民, 那希宽 . 比例法测试结核分支杆菌药物敏感性的探讨. 中华结核和呼吸杂志, 2000,23(2):89-92.
doi: 10.3760/j:issn:1001-0939.2000.02.009
URL
|
[19] |
Müller B, Borrell S, Rose G , et al. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet, 2013,29(3):160-169.
doi: 10.1016/j.tig.2012.11.005
|
[20] |
柳清云, 孙刚, 高谦 . 结核分枝杆菌(MTB) 异质性耐药研究进展. 复旦学报(医学版), 2013,40(1):1-4.
doi: 10.3969/j.issn.1672-8467.2013.01.001
URL
|
[21] |
Trauner A, Liu Q, Via LE , et al. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy. Genome Biol, 2017,18(1):71.
|